MSK-IMPACT™, Solid Organ Gene Cancer Panel
The Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) assay is a qualitative in vitro diagnostic test that uses a broad multigene panel (468-gene oncopanel) to detect tumor gene alterations in malignant neoplasms. It is a hybridization capture-based next-generation sequencing assay for targeted deep sequencing of all exons and selected introns of cancer genes in formalin-fixed, paraffin-embedded tumors.
MSK-IMPACT sequences both tumor and normal tissue from the patient to identify somatic gene alterations. It can detect point mutations, small insertions and deletions, microsatellite instability (MSI) and other mutations in genes of both rare and common cancers. Based on the results of testing patients can then be matched with available therapies or clinical trials that will most benefit them.
To date, more than 20,000 MSK patients with advanced cancers have had their tumors sequenced through MSK-IMPACT, and the resulting data has helped guide therapy while providing a wealth of new information about the genomic features of both common and rare cancer types. In 2017, MSK-IMPACT panel test was authorized by US food and drug administration (FDA) for tumor profiling.
- Identify gene mutations that impact treatment options in patients with solid tumors
- Identify inherited mutations that are risk factors for developing cancer
Normal:
- No Mutation or gene variation (pathogenic variants) in tumor and patient-matched normal samples
Abnormal:
- Mutation or gene variation (pathogenic variants) in tumor and normal samples of patients
No pathogenic variants detected
Formalin-fixed paraffin embedded (FFPE) tumor tissue specimens, Whole blood (EDTA).
Stability (Blood)
- Ambient: 3-5 days
- Refrigerated: 7 days
- FFPE is stored at room temperature.
- J Mol Diagn. 2015; 17: 251–264. [PMID: 25801821]
- Nat Med. 2017; 23: 703–713. [PMID: 28481359]
- BMC Med Genomics. 2017; 10: 33. [PMID: 28526081]
- Int J Mol Sci. 2017; 18: 308 [PMID: 28146134]
- Genome Med. 2016; 8: 62 [PMID: 27245685]
- Hum Genet. 2014;133:1-9. [PMID: 24077912]